5th Pharmacovigilance Congregation 2013

Key Topics

• Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
• Exploiting the latest technologies, methodologies & automations on work practices of Pharmacovigilance
• How will PV activities change with Clinical Trial Transformation Initiative?
• Recent successful strategies and business models to bring out new medicines
• Exploiting the pharmacy automations and technologies for enhancement of medication safety
• Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
• Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
• Stay ahead of computing and electronic communications in pharmacovigilance
• Determining the steps and strategies for enhancing quality in healthcare
• Establishing the importance of pharmacovigilance for the safety of the patient
• Analyzing the information on current industry projects and trends
• Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
• Global marketing strategies in order to engage with regulatory centres of excellence on pharmacovigilance
• Identifying the latest regulatory framework for pharmacovigilance
• Explaining how to use the data sources and observational research for effective safety analysis
• Accelerating new medicine introduction in developing world & overcoming challenges
• Be part of a major networking opportunity
• Good supply chain management practices for medicine distribution

Who should Attend

Pharmaceutical, biotech, and regulatory representatives.